These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24121879)

  • 1. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of lymphadenectomy in patients receiving neoadjuvant radiotherapy for rectal adenocarcinoma.
    Le M; Nelson R; Lee W; Mailey B; Duldulao M; Chen YJ; Garcia-Aguilar J; Kim J
    Ann Surg Oncol; 2012 Nov; 19(12):3713-8. PubMed ID: 22688661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and Late Outcomes of Surgery for Locally Recurrent Rectal Cancer: A Prospective 10-Year Study in the Total Mesorectal Excision Era.
    Nielsen M; Rasmussen P; Pedersen B; Hagemann-Madsen R; Lindegaard J; Laurberg S
    Ann Surg Oncol; 2015 Aug; 22(8):2677-84. PubMed ID: 25564165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance in rectal cancer treatment.
    van de Velde CJ; van den Broek CB
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
    Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
    Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early outcomes for rectal cancer surgery in the republic of ireland following a national centralization program.
    Burke JP; Coffey JC; Boyle E; Keane F; McNamara DA
    Ann Surg Oncol; 2013 Oct; 20(11):3414-21. PubMed ID: 23907311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
    Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
    Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal carcinoma and local recurrence].
    Mannaerts GH; Martijn H; Rutten HJ; Hanssens PE; Wiggers T
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1460-6. PubMed ID: 11503316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
    Suh KW; Kim BW; Chun M; Lim HY
    Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in ambulatory patients with inoperable locoregionally recurrent rectal cancer following curative surgery.
    Pergolizzi S; Settineri N; Santacaterina A; Maisano R; Frosina P; Loria F; Nardella G; Garufi G; Sansotta G; De Renzis C
    Anticancer Res; 1999; 19(2B):1383-90. PubMed ID: 10365110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.